Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response

被引:26
作者
Geerts, Hugo [1 ]
Spiros, Athan [1 ]
Roberts, Patrick [1 ]
Twyman, Roy [2 ]
Alphs, Larry [3 ]
Grace, Anthony A. [4 ]
机构
[1] In Silico Biosci, Berwyn, PA USA
[2] Johnson & Johnson Pharmaceut Res & Dev, Cent Nervous Syst Dev, Titusville, NJ USA
[3] Janssen Sci Affairs LLC, Titusville, NJ USA
[4] Univ Pittsburgh, Dept Neurosci Psychiat & Psychol, Pittsburgh, PA USA
来源
PLOS ONE | 2012年 / 7卷 / 12期
关键词
DOPAMINE-D-2; RECEPTOR-BINDING; ATYPICAL ANTIPSYCHOTICS; SEROTONIN RECEPTOR; IN-VIVO; OCCUPANCY; PROTEIN; D-2; HALOPERIDOL; RISPERIDONE; ANTAGONIST;
D O I
10.1371/journal.pone.0049732
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tremendous advances in understanding the neurobiological circuits involved in schizophrenia have not translated into more effective treatments. An alternative strategy is to use a recently published 'Quantitative Systems Pharmacology' computer-based mechanistic disease model of cortical/subcortical and striatal circuits based upon preclinical physiology, human pathology and pharmacology. The physiology of 27 relevant dopamine, serotonin, acetylcholine, norepinephrine, gamma-aminobutyric acid (GABA) and glutamate-mediated targets is calibrated using retrospective clinical data on 24 different antipsychotics. The model was challenged to predict quantitatively the clinical outcome in a blinded fashion of two experimental antipsychotic drugs; JNJ37822681, a highly selective low-affinity dopamine D2 antagonist and ocaperidone, a very high affinity dopamine D2 antagonist, using only pharmacology and human positron emission tomography (PET) imaging data. The model correctly predicted the lower performance of JNJ37822681 on the positive and negative syndrome scale (PANSS) total score and the higher extra-pyramidal symptom (EPS) liability compared to olanzapine and the relative performance of ocaperidone against olanzapine, but did not predict the absolute PANSS total score outcome and EPS liability for ocaperidone, possibly due to placebo responses and EPS assessment methods. Because of its virtual nature, this modeling approach can support central nervous system research and development by accounting for unique human drug properties, such as human metabolites, exposure, genotypes and off-target effects and can be a helpful tool for drug discovery and development. Citation: Geerts H, Spiros A, Roberts P, Twyman R, Alphs L, et al. (2012) Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response. PLoS ONE 7(12): e49732. doi:10.1371/journal.pone.0049732
引用
收藏
页数:11
相关论文
共 64 条
[1]   Impact of Serotonin 2C Receptor Null Mutation on Physiology and Behavior Associated with Nigrostriatal Dopamine Pathway Function [J].
Abdallah, Luna ;
Bonasera, Stephen J. ;
Hopf, F. Woodward ;
O'Dell, Laura ;
Giorgetti, Marco ;
Jongsma, Minke ;
Carra, Scott ;
Pierucci, Massimo ;
Di Giovanni, Giuseppe ;
Esposito, Ennio ;
Parsons, Loren H. ;
Bonci, Antonello ;
Tecott, Laurence H. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (25) :8156-8165
[2]   Increased baseline occupancy of D2 receptors by dopamine in schizophrenia [J].
Abi-Dargham, A ;
Rodenhiser, J ;
Printz, D ;
Zea-Ponce, Y ;
Gil, R ;
Kegeles, LS ;
Weiss, R ;
Cooper, TB ;
Mann, JJ ;
Van Heertum, RL ;
Gorman, JM ;
Laruelle, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :8104-8109
[3]   Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital [J].
Advokat, C ;
Dixon, D ;
Schneider, J ;
Comaty, JE .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (03) :487-495
[4]   Delayed-onset hypothesis of antipsychotic action - A hypothesis tested and rejected [J].
Agid, O ;
Kapur, S ;
Arenovich, T ;
Zipursky, RB .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (12) :1228-1235
[5]  
Alphs L, 2012, INT J NEUROPSYCHOPH, V15, P1, DOI DOI 10.1017/S1461145711001738
[6]   A DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA [J].
ANDERSEN, J ;
KORNER, A ;
OSTERGAARD, P ;
FENSBO, C ;
BIRKETSMITH, M ;
THIESEN, S ;
HANSEN, NR ;
FOGH, M ;
KRISTENSEN, M ;
MOLLERNIELSEN, EM ;
JENSEN, B ;
BJORUM, N .
ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 :104-107
[7]  
[Anonymous], 2011, NIH QSP WORKSH GROUP
[8]   Multiple fixed doses of ''Seroquel'' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo [J].
Arvanitis, LA ;
Miller, BG ;
Borison, RL ;
Pitts, WM ;
Sharif, ZA ;
Hamner, MB ;
Herz, MI ;
True, JE ;
Velligan, D ;
Knesevich, MA ;
Small, J ;
Steinbook, R ;
Hertzman, M ;
Keck, PE ;
Newcomer, JW ;
Grace, J ;
Rotrosen, J ;
Tandon, R ;
Dott, SG ;
Ferguson, JM ;
Addington, DEN ;
MacEwan, GW ;
Nair, VNP ;
Shriqui, CL ;
Williams, R ;
Daniel, DG ;
Shehi, GM ;
Patterson, WM ;
Merideth, CH .
BIOLOGICAL PSYCHIATRY, 1997, 42 (04) :233-246
[9]   The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain [J].
Aznar, S ;
Qian, ZX ;
Shah, R ;
Rahbek, B ;
Knudsen, GM .
BRAIN RESEARCH, 2003, 959 (01) :58-67
[10]   Dopamine modulates release from corticostriatal terminals [J].
Bamford, NS ;
Robinson, S ;
Palmiter, RD ;
Joyce, JA ;
Moore, C ;
Meshul, CK .
JOURNAL OF NEUROSCIENCE, 2004, 24 (43) :9541-9552